Now showing items 1-5 of 5
Low-Dose Carbon Monoxide Exposure in Pregnancy; a Potential Therapeutic for Pre-Eclampsia
Preeclampsia (PE) is a maternal disorder of pregnancy, characterized by late-onset hypertension and proteinuria. It affects roughly 5-7% of all pregnancies worldwide and is a leading cause of maternal and fetal/neonatal ...
The Role of Abnormal Maternal Inflammation in the Pathogenesis of Pregnancy Complications
Pre-eclampsia (PE), fetal growth restriction (FGR) and fetal death are common complications associated with human pregnancy. A hallmark of these adverse pregnancy outcomes is reduced utero-placental perfusion, which is ...
Analysis of parameters of haemostasis in pre-eclamptic, normotensive pregnant and non-pregnant women.
Pregnancy is characterized by a state of heightened coagulation, which is exacerbated in pathological conditions such as pre-eclampsia (PET). PET is further associated with abnormal maternal inflammation and increased ...
Carbon Monoxide and Pregnancy: a Search for a Possible Therapeutic in the Treatment of Pre-Eclampsia
Pre-eclampsia (PE) is a pregnancy disorder that affects roughly 5-7% of all pregnancies and is a leading cause of both maternal and fetal/neonatal morbidity and mortality. With no present cure for the disease, researchers ...
Markers of Cardiovascular Dysfunction After Pregnancies Complicated by Pre-Eclampsia
Pre-eclampsia (PE) is a hypertensive disorder of pregnancy characterized by maternal systemic endothelial dysfunction. While the clinical manifestations resolve soon after delivery, a large body of epidemiological evidence ...